Deutsche Bank’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-383
Closed -$5.66K 3712
2024
Q1
$5.66K Sell
383
-596
-61% -$8.8K ﹤0.01% 3487
2023
Q4
$13.1K Buy
979
+69
+8% +$925 ﹤0.01% 3461
2023
Q3
$11.2K Buy
+910
New +$11.2K ﹤0.01% 3505
2020
Q2
Sell
-1,103
Closed -$2K 4490
2020
Q1
$2K Sell
1,103
-20,028
-95% -$36.3K ﹤0.01% 4051
2019
Q4
$65K Sell
21,131
-4,491
-18% -$13.8K ﹤0.01% 3736
2019
Q3
$114K Sell
25,622
-7,198
-22% -$32K ﹤0.01% 3424
2019
Q2
$155K Sell
32,820
-4,733
-13% -$22.4K ﹤0.01% 3877
2019
Q1
$204K Buy
37,553
+2,034
+6% +$11K ﹤0.01% 3896
2018
Q4
$107K Sell
35,519
-3,178
-8% -$9.57K ﹤0.01% 4047
2018
Q3
$163K Buy
38,697
+8,265
+27% +$34.8K ﹤0.01% 4192
2018
Q2
$117K Sell
30,432
-303,461
-91% -$1.17M ﹤0.01% 4326
2018
Q1
$2.11M Buy
333,893
+151,161
+83% +$957K ﹤0.01% 2804
2017
Q4
$1.47M Sell
182,732
-19,165
-9% -$154K ﹤0.01% 2911
2017
Q3
$2.31M Buy
201,897
+34,441
+21% +$394K ﹤0.01% 2423
2017
Q2
$1.63M Buy
167,456
+18,882
+13% +$184K ﹤0.01% 2665
2017
Q1
$3.6M Sell
148,574
-26,672
-15% -$646K ﹤0.01% 1867
2016
Q4
$5.62M Sell
175,246
-11,707
-6% -$376K ﹤0.01% 1595
2016
Q3
$9.34M Sell
186,953
-9,213
-5% -$460K 0.01% 1353
2016
Q2
$8.32M Sell
196,166
-35,107
-15% -$1.49M 0.01% 1416
2016
Q1
$15.2M Buy
231,273
+8,250
+4% +$543K 0.01% 1028
2015
Q4
$13.9M Sell
223,023
-1,841
-0.8% -$114K 0.01% 1128
2015
Q3
$15.1M Sell
224,864
-5,504
-2% -$368K 0.01% 1054
2015
Q2
$22.4M Buy
230,368
+3,043
+1% +$296K 0.01% 876
2015
Q1
$21.2M Sell
227,325
-19,069
-8% -$1.78M 0.01% 897
2014
Q4
$21.9M Buy
246,394
+6,144
+3% +$546K 0.01% 957
2014
Q3
$16.6M Sell
240,250
-69,369
-22% -$4.79M 0.01% 1028
2014
Q2
$17.8M Buy
309,619
+211,292
+215% +$12.1M 0.01% 1007
2014
Q1
$3.9M Buy
98,327
+8,901
+10% +$353K ﹤0.01% 1995
2013
Q4
$3.75M Sell
89,426
-10,008
-10% -$420K ﹤0.01% 1938
2013
Q3
$2.96M Buy
99,434
+80,716
+431% +$2.41M ﹤0.01% 2205
2013
Q2
$992K Buy
+18,718
New +$992K ﹤0.01% 2704